• Je něco špatně v tomto záznamu ?

Correlating plasma protein profiles with symptomatology and treatment response in acute phase and early remission of major depressive disorder

P. Křenek, E. Bartečková, M. Makarová, T. Pompa, J. Fialová Kučerová, J. Kučera, A. Damborská, J. Hořínková, J. Bienertová-Vašků

. 2024 ; 15 (-) : 1425552. [pub] 20240917

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25002478

OBJECTIVES: This study aimed to explore the relationship between plasma proteome and the clinical features of Major Depressive Disorder (MDD) during treatment of acute episode. METHODS: In this longitudinal observational study, 26 patients hospitalized for moderate to severe MDD were analyzed. The study utilized Liquid Chromatography with Tandem Mass Spectrometry (LC-MS/MS) alongside clinical metrics, including symptomatology derived from the Montgomery-Åsberg Depression Rating Scale (MADRS). Plasma protein analysis was conducted at the onset of acute depression and 6 weeks into treatment. Analytical methods comprised of Linear Models for Microarray Data (LIMMA), Weighted Correlation Network Analysis (WGCNA), Generalized Linear Models, Random Forests, and The Database for Annotation, Visualization and Integrated Discovery (DAVID). RESULTS: Five distinct plasma protein modules were identified, correlating with specific biological processes, and uniquely associated with symptom presentation, the disorder's trajectory, and treatment response. A module rich in proteins related to adaptive immunity was correlated with the manifestation of somatic syndrome, treatment response, and inversely associated with achieving remission. A module associated with cell adhesion was linked to affective symptoms and avolition, and played a role in the initial episodes and treatment response. Another module, characterized by proteins involved in blood coagulation and lipid transport, exhibited negative correlations with a variety of MDD symptoms and was predominantly associated with the manifestation of psychotic symptoms. CONCLUSION: This research points to a complex interplay between the plasma proteome and MDD's clinical presentation, suggesting that somatic, affective, and psychotic symptoms may represent distinct endophenotypic manifestations of MDD. These insights hold potential for advancing targeted therapeutic strategies and diagnostic tools. LIMITATIONS: The study's limited sample size and its naturalistic design, encompassing diverse treatment modalities, present methodological constraints. Furthermore, the analysis focused on peripheral blood proteins, with potential implications for interpretability.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25002478
003      
CZ-PrNML
005      
20250123101911.0
007      
ta
008      
250117e20240917sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fpsyt.2024.1425552 $2 doi
035    __
$a (PubMed)39355377
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Křenek, Pavel $u Department of Psychiatry, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czechia
245    10
$a Correlating plasma protein profiles with symptomatology and treatment response in acute phase and early remission of major depressive disorder / $c P. Křenek, E. Bartečková, M. Makarová, T. Pompa, J. Fialová Kučerová, J. Kučera, A. Damborská, J. Hořínková, J. Bienertová-Vašků
520    9_
$a OBJECTIVES: This study aimed to explore the relationship between plasma proteome and the clinical features of Major Depressive Disorder (MDD) during treatment of acute episode. METHODS: In this longitudinal observational study, 26 patients hospitalized for moderate to severe MDD were analyzed. The study utilized Liquid Chromatography with Tandem Mass Spectrometry (LC-MS/MS) alongside clinical metrics, including symptomatology derived from the Montgomery-Åsberg Depression Rating Scale (MADRS). Plasma protein analysis was conducted at the onset of acute depression and 6 weeks into treatment. Analytical methods comprised of Linear Models for Microarray Data (LIMMA), Weighted Correlation Network Analysis (WGCNA), Generalized Linear Models, Random Forests, and The Database for Annotation, Visualization and Integrated Discovery (DAVID). RESULTS: Five distinct plasma protein modules were identified, correlating with specific biological processes, and uniquely associated with symptom presentation, the disorder's trajectory, and treatment response. A module rich in proteins related to adaptive immunity was correlated with the manifestation of somatic syndrome, treatment response, and inversely associated with achieving remission. A module associated with cell adhesion was linked to affective symptoms and avolition, and played a role in the initial episodes and treatment response. Another module, characterized by proteins involved in blood coagulation and lipid transport, exhibited negative correlations with a variety of MDD symptoms and was predominantly associated with the manifestation of psychotic symptoms. CONCLUSION: This research points to a complex interplay between the plasma proteome and MDD's clinical presentation, suggesting that somatic, affective, and psychotic symptoms may represent distinct endophenotypic manifestations of MDD. These insights hold potential for advancing targeted therapeutic strategies and diagnostic tools. LIMITATIONS: The study's limited sample size and its naturalistic design, encompassing diverse treatment modalities, present methodological constraints. Furthermore, the analysis focused on peripheral blood proteins, with potential implications for interpretability.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bartečková, Eliška $u Department of Psychiatry, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czechia
700    1_
$a Makarová, Markéta $u Department of Physical Activities and Health Sciences, Faculty of Sport Science, Masaryk University, Brno, Czechia
700    1_
$a Pompa, Tomáš $u Department of Physical Activities and Health Sciences, Faculty of Sport Science, Masaryk University, Brno, Czechia
700    1_
$a Fialová Kučerová, Jana $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Kučera, Jan $u Department of Physical Activities and Health Sciences, Faculty of Sport Science, Masaryk University, Brno, Czechia
700    1_
$a Damborská, Alena $u Department of Psychiatry, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czechia
700    1_
$a Hořínková, Jana $u Department of Psychiatry, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czechia
700    1_
$a Bienertová-Vašků, Julie $u Department of Physical Activities and Health Sciences, Faculty of Sport Science, Masaryk University, Brno, Czechia $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czechia
773    0_
$w MED00174602 $t Frontiers in psychiatry $x 1664-0640 $g Roč. 15 (20240917), s. 1425552
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39355377 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250117 $b ABA008
991    __
$a 20250123101905 $b ABA008
999    __
$a ok $b bmc $g 2254595 $s 1238481
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 15 $c - $d 1425552 $e 20240917 $i 1664-0640 $m Frontiers in psychiatry $n Front Psychiatry $x MED00174602
LZP    __
$a Pubmed-20250117

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...